Showing 34,862 articles by Roger Pebody

Filters Author: Roger Pebody

Roger joined NAM in 2008 as an Editor and became Managing Editor in 2018. He is responsible for co-ordinating the editorial content of aidsmap.com, including news coverage and patient information materials. His involvement in HIV work began at Gay Men Fighting AIDS in the mid-1990s. Twitter: @RogerPebody

IAS 2021: Earlier treatment and higher CD4 counts linked to smaller HIV reservoir, Thursday 22 July 2021

July 2021
Improving HIV care

What Will Bring People Living With HIV Back Into Care?

Editor's pick
POZ
22 July 2021
Injectable & long-acting PrEP

Modelling suggests injectable cabotegravir is far more effective than daily oral PrEP for women

News
22 July 2021
Transgender people

How can HIV research better align with the realities of transgender and gender-diverse people?

News
22 July 2021

IAS 2021: Rischio di COVID-19 grave più elevato con basse conte CD4 e mancata soppressione HIV, Mercoledì 21 luglio 2021

July 2021
Drug-resistant TB

Shorter, less toxic treatment for highly drug-resistant TB cures nine out of ten

News
21 July 2021
The search for a cure

Earlier treatment and higher CD4 counts linked to smaller HIV reservoir

News
21 July 2021

IAS 2021: Tener niveles bajos de CD4 y una carga viral del VIH detectable aumentan el riesgo de sufrir un caso grave de COVID-19, Miércoles, 21 de julio de 2021

July 2021

IAS 2021: Un taux faible de cellules T CD4 et une charge virale détectable augmentent les risques de COVID-19 grave, Mercredi 21 juillet 2021

July 2021

IAS 2021: Contagem de CD4 mais baixa e VIH não suprimido aumentam o risco de COVID-19 grave, Quarta-feira, 21 de julho de 2021

July 2021
Injectable & long-acting PrEP

IAS: Merck's long-acting HIV med hits protective levels in phase 2

Editor's pick
FierceBiotech
21 July 2021

IAS 2021: Lower CD4 count and unsuppressed HIV raise risk for severe COVID-19, Wednesday 21 July 2021

July 2021
PrEP policies & guidelines

US: PrEP, the HIV prevention pill, must now be totally free under almost all insurance plans

Editor's pick
NBC News
21 July 2021
New & experimental HIV treatments

HIV: Could Another Two-Drug Regimen Be on the Horizon?

Editor's pick
Medscape (requires free registration)
21 July 2021
Drug-resistant TB

US: Prevalence of transmitted resistance to common HIV drugs remains stable

Editor's pick
Healio
21 July 2021
HIV testing policies & guidelines

Increasing and normalising HIV testing across the UK

Editor's pick
All-Party Parliamentary Group on HIV and AIDS
21 July 2021
Sexually transmitted infections epidemiology

Trends in STD case reports during the U.S. COVID-19 pandemic, January-December 2020

Editor's pick
Centers for Disease Control and Prevention
21 July 2021

IAS 2021: Низкий уровень CD4 и определяемая вирусная нагрузка повышают риск тяжелого течения COVID-19, Среда, 21 июля 2021 г.

July 2021
PrEP science

PrEP failures in African programmes are rare, but some are happening in people with good adherence

News
21 July 2021
Viral load

Viral suppression in Uganda improved by more viral load tests, done faster

News
20 July 2021

IAS 2021: Мероприятия, проводимые среди подростков, приводят к улучшению вирусологического контроля, Вторник, 20 июля 2021 г.

July 2021
Retention & linkage to care

Multiple African countries improved access to HIV treatment during COVID-19 pandemic

News
20 July 2021

IAS 2021: Gli interventi mirati sugli adolescenti migliorano la soppressione virale, Martedì 20 luglio 2021

July 2021

IAS 2021: Las intervenciones centradas en los adolescentes consiguen mejorar las tasas de supresión de la carga viral, Martes, 20 de julio de 2021

July 2021